Cantor Fitzgerald Maintains Overweight on HCA Healthcare, Lowers Price Target to $525

Benzinga Newsdesk www.benzinga.com Negative 87.8%

Neg 87.8% Neu 0% Pos 0%

Cantor Fitzgerald analyst Sarah James maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $588 to $525.